BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8163252)

  • 21. Efficacy and safety of pravastatin in hypertensive hypercholesterolaemic patients on antihypertensive drug therapy.
    Celis H; Lijnen P; Fagard R; Staessen J; Thijs L; Amery A
    J Hum Hypertens; 1994 Jul; 8(7):525-30. PubMed ID: 7932517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pravastatin vs. probucol in the treatment of hypercholesterolemia. A double-blind study].
    Sienra-Pérez JC; Lerman-Garber I; Ahumada-Ayala M; Castañón-Romo C; Cardoso-Saldaña G; Laguna-Castellanos M; Posadas-Romero C
    Arch Inst Cardiol Mex; 1991; 61(4):365-73. PubMed ID: 1953212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pravastatin therapy and the risk of stroke.
    White HD; Simes RJ; Anderson NE; Hankey GJ; Watson JD; Hunt D; Colquhoun DM; Glasziou P; MacMahon S; Kirby AC; West MJ; Tonkin AM
    N Engl J Med; 2000 Aug; 343(5):317-26. PubMed ID: 10922421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
    Morris R; Robinson G; Tilyard M; Gurr E
    N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pravastatin treatment on vitamin D metabolites.
    Montagnani M; Loré F; Di Cairano G; Gonnelli S; Ciuoli C; Montagnani A; Gennari C
    Clin Ther; 1994; 16(5):824-9. PubMed ID: 7859242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An evaluation of the efficacy and safety of pravastatin in patients with primary hypercholesterolemia. A Brazilian open multicenter study].
    Giannini SD
    Arq Bras Cardiol; 1992 Oct; 59(4):319-27. PubMed ID: 1341189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study].
    Romics L; Karádi I; Csanády M; Gógl A; Jánosi A; Ofner P; Tarján J; Varga L; Wórum F; Zeltner G
    Orv Hetil; 1994 Oct; 135(40):2187-91. PubMed ID: 7970631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pravastatin, a new cholesterol synthesis inhibitor for lowering increased serum cholesterol].
    Hoppichler F; Lechleitner M; Patsch JR
    Z Gesamte Inn Med; 1992 Nov; 47(11):523-7. PubMed ID: 1462678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multinational study of the effects of low-dose pravastatin in patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia. Pravastatin Multinational Study Group for Diabetes.
    Behounek BD; McGovern ME; Kassler-Taub KB; Markowitz JS; Bergman M
    Clin Cardiol; 1994 Oct; 17(10):558-62. PubMed ID: 8001304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.
    Raskin P; Ganda OP; Schwartz S; Willard D; Rosenstock J; Lodewick PA; Cressman MD; Phillipson B; Weiner B; McGovern ME
    Am J Med; 1995 Oct; 99(4):362-9. PubMed ID: 7573090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pravastatin: efficacy and safety in elderly patients with primary hypercholesterolemia. Open multicenter study].
    Giannini SD; Diament J
    Arq Bras Cardiol; 1993 Aug; 61(2):131-7. PubMed ID: 8297223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.
    Pfeffer MA; Sacks FM; Moyé LA; East C; Goldman S; Nash DT; Rouleau JR; Rouleau JL; Sussex BA; Theroux P; Vanden Belt RJ; Braunwald E
    J Am Coll Cardiol; 1999 Jan; 33(1):125-30. PubMed ID: 9935018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. The Simvastatin Pravastatin Study Group.
    Am J Cardiol; 1993 Jun; 71(16):1408-14. PubMed ID: 8517385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia.
    Santinga JT; Rosman HS; Rubenfire M; Maciejko JJ; Kobylak L; McGovern ME; Behounek BD
    Am J Med; 1994 Jun; 96(6):509-15. PubMed ID: 8017448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus.
    Krempf M; Berthezène F; Wemeau JL; Moinade S; Desriac I; Amelineau E; Passa P
    Diabetes Metab; 1997 Apr; 23(2):131-6. PubMed ID: 9137901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia.
    Chan P; Tomlinson B; Lee CB; Lee YS
    J Clin Pharmacol; 1996 May; 36(5):422-7. PubMed ID: 8739021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.